APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antiasthmatic Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antiasthmatic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026195 pages

Choose your research edition.

Industry ResearchAntiasthmatic Drug Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiasthmatic Drug Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Antiasthmatic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiasthmatic Drug Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiasthmatic Drug Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Antiasthmatic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Antiasthmatic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antiasthmatic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiasthmatic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antiasthmatic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiasthmatic Drug include Ruiyang Pharmaceutical Co., Ltd, Novartis AG, Roche, Lunan Pharmaceutical Group Co., Ltd, Kaifeng Kangnuo Pharmaceutical Co., Ltd, GlaxoSmithKline, Fuhe Group, Chengdu Huayu Pharmaceutical Co., Ltd and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Antiasthmatic Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antiasthmatic Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antiasthmatic Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Antiasthmatic Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Antiasthmatic Drug Segment by Company

Ruiyang Pharmaceutical Co., Ltd

Novartis AG

Roche

Lunan Pharmaceutical Group Co., Ltd

Kaifeng Kangnuo Pharmaceutical Co., Ltd

GlaxoSmithKline

Fuhe Group

Chengdu Huayu Pharmaceutical Co., Ltd

AstraZeneca

Teva Pharmaceutical Industries Ltd

Mundipharma Pharmaceuticals Ltd.

MSD

Kyorin Pharmaceutical Co.,Ltd.

Kissei Pharmaceutical Co.Ltd.

Daiichi Sankyo Company Limited

Covis Pharmaceutical Inc

Chiesi GmbH

Boehringer Ingelheim Pharma GmbH&Co.KG

Akorn Pharmaceutical Co.Ltd.

ABC Farmaceutici Spa

Antiasthmatic Drug Segment by Type

Anti-allergic Antiasthmatic

Anti-inflammatory Antiasthmatic

Bronchodilators

Antiasthmatic Drug Segment by Application

Hospital

Clinic

Other

Antiasthmatic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiasthmatic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiasthmatic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiasthmatic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Antiasthmatic Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antiasthmatic Drug industry.

Chapter 3: Detailed analysis of Antiasthmatic Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antiasthmatic Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antiasthmatic Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Anti-allergic Antiasthmatic Table 3. Key Players of Anti-inflammatory Antiasthmatic Table 4. Key Players of Bronchodilators Table 4. Global Antiasthmatic Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Antiasthmatic Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Antiasthmatic Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Antiasthmatic Drug Market Share by Region (2021-2026) Table 11. Global Antiasthmatic Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Antiasthmatic Drug Market Share by Region (2027-2032) Table 13. Antiasthmatic Drug Industry Trends Table 14. Antiasthmatic Drug Industry Drivers Table 15. Antiasthmatic Drug Industry Opportunities and Challenges Table 16. Antiasthmatic Drug Industry Restraints Table 17. Global Antiasthmatic Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Antiasthmatic Drug Revenue Market Share by Company (2021-2026) Table 19. Global Antiasthmatic Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Antiasthmatic Drug Key Company Head Office and Area Served Table 21. Global Antiasthmatic Drug Company, Product Type & Application Table 22. Global Antiasthmatic Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Antiasthmatic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Antiasthmatic Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Antiasthmatic Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Antiasthmatic Drug Revenue Market Share by Type (2021-2026) Table 29. Global Antiasthmatic Drug Revenue Market Share by Type (2027-2032) Table 30. Global Antiasthmatic Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Antiasthmatic Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Antiasthmatic Drug Revenue Market Share by Application (2021-2026) Table 34. Global Antiasthmatic Drug Revenue Market Share by Application (2027-2032) Table 35. Ruiyang Pharmaceutical Co., Ltd Company Information Table 36. Ruiyang Pharmaceutical Co., Ltd Business Overview Table 37. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio Table 39. Ruiyang Pharmaceutical Co., Ltd Recent Development Table 40. Novartis AG Company Information Table 41. Novartis AG Business Overview Table 42. Novartis AG Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis AG Antiasthmatic Drug Product Portfolio Table 44. Novartis AG Recent Development Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Roche Antiasthmatic Drug Product Portfolio Table 49. Roche Recent Development Table 50. Lunan Pharmaceutical Group Co., Ltd Company Information Table 51. Lunan Pharmaceutical Group Co., Ltd Business Overview Table 52. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Portfolio Table 54. Lunan Pharmaceutical Group Co., Ltd Recent Development Table 55. Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Information Table 56. Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview Table 57. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio Table 59. Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Development Table 60. GlaxoSmithKline Company Information Table 61. GlaxoSmithKline Business Overview Table 62. GlaxoSmithKline Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. GlaxoSmithKline Antiasthmatic Drug Product Portfolio Table 64. GlaxoSmithKline Recent Development Table 65. Fuhe Group Company Information Table 66. Fuhe Group Business Overview Table 67. Fuhe Group Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Fuhe Group Antiasthmatic Drug Product Portfolio Table 69. Fuhe Group Recent Development Table 70. Chengdu Huayu Pharmaceutical Co., Ltd Company Information Table 71. Chengdu Huayu Pharmaceutical Co., Ltd Business Overview Table 72. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio Table 74. Chengdu Huayu Pharmaceutical Co., Ltd Recent Development Table 75. AstraZeneca Company Information Table 76. AstraZeneca Business Overview Table 77. AstraZeneca Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. AstraZeneca Antiasthmatic Drug Product Portfolio Table 79. AstraZeneca Recent Development Table 80. Teva Pharmaceutical Industries Ltd Company Information Table 81. Teva Pharmaceutical Industries Ltd Business Overview Table 82. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Portfolio Table 84. Teva Pharmaceutical Industries Ltd Recent Development Table 85. Mundipharma Pharmaceuticals Ltd. Company Information Table 86. Mundipharma Pharmaceuticals Ltd. Business Overview Table 87. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Portfolio Table 89. Mundipharma Pharmaceuticals Ltd. Recent Development Table 90. MSD Company Information Table 91. MSD Business Overview Table 92. MSD Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. MSD Antiasthmatic Drug Product Portfolio Table 94. MSD Recent Development Table 95. Kyorin Pharmaceutical Co.,Ltd. Company Information Table 96. Kyorin Pharmaceutical Co.,Ltd. Business Overview Table 97. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Portfolio Table 99. Kyorin Pharmaceutical Co.,Ltd. Recent Development Table 100. Kissei Pharmaceutical Co.Ltd. Company Information Table 101. Kissei Pharmaceutical Co.Ltd. Business Overview Table 102. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio Table 104. Kissei Pharmaceutical Co.Ltd. Recent Development Table 105. Daiichi Sankyo Company Limited Company Information Table 106. Daiichi Sankyo Company Limited Business Overview Table 107. Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Daiichi Sankyo Company Limited Antiasthmatic Drug Product Portfolio Table 109. Daiichi Sankyo Company Limited Recent Development Table 110. Covis Pharmaceutical Inc Company Information Table 111. Covis Pharmaceutical Inc Business Overview Table 112. Covis Pharmaceutical Inc Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. Covis Pharmaceutical Inc Antiasthmatic Drug Product Portfolio Table 114. Covis Pharmaceutical Inc Recent Development Table 115. Chiesi GmbH Company Information Table 116. Chiesi GmbH Business Overview Table 117. Chiesi GmbH Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. Chiesi GmbH Antiasthmatic Drug Product Portfolio Table 119. Chiesi GmbH Recent Development Table 120. Boehringer Ingelheim Pharma GmbH&Co.KG Company Information Table 121. Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview Table 122. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Portfolio Table 124. Boehringer Ingelheim Pharma GmbH&Co.KG Recent Development Table 125. Akorn Pharmaceutical Co.Ltd. Company Information Table 126. Akorn Pharmaceutical Co.Ltd. Business Overview Table 127. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio Table 129. Akorn Pharmaceutical Co.Ltd. Recent Development Table 130. ABC Farmaceutici Spa Company Information Table 131. ABC Farmaceutici Spa Business Overview Table 132. ABC Farmaceutici Spa Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. ABC Farmaceutici Spa Antiasthmatic Drug Product Portfolio Table 134. ABC Farmaceutici Spa Recent Development Table 135. North America Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million) Table 136. North America Antiasthmatic Drug Market Size by Type (2027-2032) & (US$ Million) Table 137. North America Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million) Table 138. North America Antiasthmatic Drug Market Size by Application (2027-2032) & (US$ Million) Table 139. North America Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. North America Antiasthmatic Drug Market Size by Country (2021-2026) Table 141. North America Antiasthmatic Drug Market Size by Country (2027-2032) Table 142. Europe Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million) Table 143. Europe Antiasthmatic Drug Market Size by Type (2027-2032) & (US$ Million) Table 144. Europe Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million) Table 145. Europe Antiasthmatic Drug Market Size by Application (2027-2032) & (US$ Million) Table 146. Europe Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Europe Antiasthmatic Drug Market Size by Country (2021-2026) Table 148. Europe Antiasthmatic Drug Market Size by Country (2027-2032) Table 149. China Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million) Table 150. China Antiasthmatic Drug Market Size by Type (2027-2032) & (US$ Million) Table 151. China Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million) Table 152. China Antiasthmatic Drug Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million) Table 154. Asia Antiasthmatic Drug Market Size by Type (2027-2032) & (US$ Million) Table 155. Asia Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million) Table 156. Asia Antiasthmatic Drug Market Size by Application (2027-2032) & (US$ Million) Table 157. Asia Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Asia Antiasthmatic Drug Market Size by Country (2021-2026) Table 159. Asia Antiasthmatic Drug Market Size by Country (2027-2032) Table 160. South America, Middle East & Africa Antiasthmatic Drug Market Size by Type (2021-2026) & (US$ Million) Table 161. South America, Middle East & Africa Antiasthmatic Drug Market Size by Type (2027-2032) & (US$ Million) Table 162. South America, Middle East & Africa Antiasthmatic Drug Market Size by Application (2021-2026) & (US$ Million) Table 163. South America, Middle East & Africa Antiasthmatic Drug Market Size by Application (2027-2032) & (US$ Million) Table 164. South America, Middle East & Africa Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. South America, Middle East & Africa Antiasthmatic Drug Market Size by Country (2021-2026) Table 166. South America, Middle East & Africa Antiasthmatic Drug Market Size by Country (2027-2032) Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Antiasthmatic Drug Product Image Figure 2. Global Antiasthmatic Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Antiasthmatic Drug Market Share by Type: 2025 VS 2032 Figure 4. Anti-allergic Antiasthmatic Image Figure 5. Anti-inflammatory Antiasthmatic Image Figure 6. Bronchodilators Image Figure 7. Global Antiasthmatic Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Antiasthmatic Drug Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Antiasthmatic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global Antiasthmatic Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Antiasthmatic Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Antiasthmatic Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Antiasthmatic Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Antiasthmatic Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Antiasthmatic Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Antiasthmatic Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America Antiasthmatic Drug Market Share by Type (2021-2032) Figure 25. North America Antiasthmatic Drug Market Share by Application (2021-2032) Figure 26. North America Antiasthmatic Drug Market Share by Country (2021-2032) Figure 27. United States Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Antiasthmatic Drug Market Share by Type (2021-2032) Figure 32. Europe Antiasthmatic Drug Market Share by Application (2021-2032) Figure 33. Europe Antiasthmatic Drug Market Share by Country (2021-2032) Figure 34. Germany Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 35. France Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 40. China Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Antiasthmatic Drug Market Share by Type (2021-2032) Figure 42. China Antiasthmatic Drug Market Share by Application (2021-2032) Figure 43. Asia Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia Antiasthmatic Drug Market Share by Type (2021-2032) Figure 45. Asia Antiasthmatic Drug Market Share by Application (2021-2032) Figure 46. Asia Antiasthmatic Drug Market Share by Country (2021-2032) Figure 47. Japan Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 51. India Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Antiasthmatic Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Antiasthmatic Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Antiasthmatic Drug Market Share by Country (2021-2032) Figure 57. Brazil Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile Antiasthmatic Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Anti-allergic Antiasthmatic
  • Anti-inflammatory Antiasthmatic
  • Bronchodilators
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Ruiyang Pharmaceutical Co., Ltd
  • Novartis AG
  • Roche
  • Lunan Pharmaceutical Group Co., Ltd
  • Kaifeng Kangnuo Pharmaceutical Co., Ltd
  • GlaxoSmithKline
  • Fuhe Group
  • Chengdu Huayu Pharmaceutical Co., Ltd
  • AstraZeneca
  • Teva Pharmaceutical Industries Ltd
  • Mundipharma Pharmaceuticals Ltd.
  • MSD
  • Kyorin Pharmaceutical Co.,Ltd.
  • Kissei Pharmaceutical Co.Ltd.
  • Daiichi Sankyo Company Limited
  • Covis Pharmaceutical Inc
  • Chiesi GmbH
  • Boehringer Ingelheim Pharma GmbH&Co.KG
  • Akorn Pharmaceutical Co.Ltd.
  • ABC Farmaceutici Spa

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Antiasthmatic Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Anti-allergic Antiasthmatic
  5. 1.2.3 Anti-inflammatory Antiasthmatic
  6. 1.2.4 Bronchodilators
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Antiasthmatic Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Antiasthmatic Drug Growth Trends by Region
  14. 1.5.1 Global Antiasthmatic Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Antiasthmatic Drug Market Size by Region (2021-2026)
  16. 1.5.3 Antiasthmatic Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Antiasthmatic Drug Market Dynamics
  1. 2.1 Antiasthmatic Drug Industry Trends
  2. 2.2 Antiasthmatic Drug Industry Drivers
  3. 2.3 Antiasthmatic Drug Industry Opportunities and Challenges
  4. 2.4 Antiasthmatic Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Antiasthmatic Drug Revenue by Company (2021-2026)
  2. 3.2 Global Antiasthmatic Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Antiasthmatic Drug Key Company Head office and Area Served
  4. 3.4 Global Antiasthmatic Drug Company, Product Type & Application
  5. 3.5 Global Antiasthmatic Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Antiasthmatic Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Antiasthmatic Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Antiasthmatic Drug Tier 1, Tier 2, and Tier 3
4 Antiasthmatic Drug Market by Type
  1. 4.1 Global Antiasthmatic Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Antiasthmatic Drug Market Size by Type (2021-2032)
  3. 4.3 Global Antiasthmatic Drug Market Size Share by Type (2021-2032)
5 Antiasthmatic Drug Market by Application
  1. 5.1 Global Antiasthmatic Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Antiasthmatic Drug Market Size by Application (2021-2032)
  3. 5.3 Global Antiasthmatic Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Ruiyang Pharmaceutical Co., Ltd
  2. 6.1.1 Ruiyang Pharmaceutical Co., Ltd Company Information
  3. 6.1.2 Ruiyang Pharmaceutical Co., Ltd Business Overview
  4. 6.1.3 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Ruiyang Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
  6. 6.1.5 Ruiyang Pharmaceutical Co., Ltd Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Antiasthmatic Drug Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Roche
  14. 6.3.1 Roche Company Information
  15. 6.3.2 Roche Business Overview
  16. 6.3.3 Roche Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Roche Antiasthmatic Drug Product Portfolio
  18. 6.3.5 Roche Recent Developments
  19. 6.4 Lunan Pharmaceutical Group Co., Ltd
  20. 6.4.1 Lunan Pharmaceutical Group Co., Ltd Company Information
  21. 6.4.2 Lunan Pharmaceutical Group Co., Ltd Business Overview
  22. 6.4.3 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Lunan Pharmaceutical Group Co., Ltd Antiasthmatic Drug Product Portfolio
  24. 6.4.5 Lunan Pharmaceutical Group Co., Ltd Recent Developments
  25. 6.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd
  26. 6.5.1 Kaifeng Kangnuo Pharmaceutical Co., Ltd Company Information
  27. 6.5.2 Kaifeng Kangnuo Pharmaceutical Co., Ltd Business Overview
  28. 6.5.3 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Kaifeng Kangnuo Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
  30. 6.5.5 Kaifeng Kangnuo Pharmaceutical Co., Ltd Recent Developments
  31. 6.6 GlaxoSmithKline
  32. 6.6.1 GlaxoSmithKline Company Information
  33. 6.6.2 GlaxoSmithKline Business Overview
  34. 6.6.3 GlaxoSmithKline Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 GlaxoSmithKline Antiasthmatic Drug Product Portfolio
  36. 6.6.5 GlaxoSmithKline Recent Developments
  37. 6.7 Fuhe Group
  38. 6.7.1 Fuhe Group Company Information
  39. 6.7.2 Fuhe Group Business Overview
  40. 6.7.3 Fuhe Group Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Fuhe Group Antiasthmatic Drug Product Portfolio
  42. 6.7.5 Fuhe Group Recent Developments
  43. 6.8 Chengdu Huayu Pharmaceutical Co., Ltd
  44. 6.8.1 Chengdu Huayu Pharmaceutical Co., Ltd Company Information
  45. 6.8.2 Chengdu Huayu Pharmaceutical Co., Ltd Business Overview
  46. 6.8.3 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Chengdu Huayu Pharmaceutical Co., Ltd Antiasthmatic Drug Product Portfolio
  48. 6.8.5 Chengdu Huayu Pharmaceutical Co., Ltd Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 AstraZeneca Antiasthmatic Drug Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 Teva Pharmaceutical Industries Ltd
  56. 6.10.1 Teva Pharmaceutical Industries Ltd Company Information
  57. 6.10.2 Teva Pharmaceutical Industries Ltd Business Overview
  58. 6.10.3 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Teva Pharmaceutical Industries Ltd Antiasthmatic Drug Product Portfolio
  60. 6.10.5 Teva Pharmaceutical Industries Ltd Recent Developments
  61. 6.11 Mundipharma Pharmaceuticals Ltd.
  62. 6.11.1 Mundipharma Pharmaceuticals Ltd. Company Information
  63. 6.11.2 Mundipharma Pharmaceuticals Ltd. Business Overview
  64. 6.11.3 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Mundipharma Pharmaceuticals Ltd. Antiasthmatic Drug Product Portfolio
  66. 6.11.5 Mundipharma Pharmaceuticals Ltd. Recent Developments
  67. 6.12 MSD
  68. 6.12.1 MSD Company Information
  69. 6.12.2 MSD Business Overview
  70. 6.12.3 MSD Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 MSD Antiasthmatic Drug Product Portfolio
  72. 6.12.5 MSD Recent Developments
  73. 6.13 Kyorin Pharmaceutical Co.,Ltd.
  74. 6.13.1 Kyorin Pharmaceutical Co.,Ltd. Company Information
  75. 6.13.2 Kyorin Pharmaceutical Co.,Ltd. Business Overview
  76. 6.13.3 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Kyorin Pharmaceutical Co.,Ltd. Antiasthmatic Drug Product Portfolio
  78. 6.13.5 Kyorin Pharmaceutical Co.,Ltd. Recent Developments
  79. 6.14 Kissei Pharmaceutical Co.Ltd.
  80. 6.14.1 Kissei Pharmaceutical Co.Ltd. Company Information
  81. 6.14.2 Kissei Pharmaceutical Co.Ltd. Business Overview
  82. 6.14.3 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Kissei Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
  84. 6.14.5 Kissei Pharmaceutical Co.Ltd. Recent Developments
  85. 6.15 Daiichi Sankyo Company Limited
  86. 6.15.1 Daiichi Sankyo Company Limited Company Information
  87. 6.15.2 Daiichi Sankyo Company Limited Business Overview
  88. 6.15.3 Daiichi Sankyo Company Limited Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Daiichi Sankyo Company Limited Antiasthmatic Drug Product Portfolio
  90. 6.15.5 Daiichi Sankyo Company Limited Recent Developments
  91. 6.16 Covis Pharmaceutical Inc
  92. 6.16.1 Covis Pharmaceutical Inc Company Information
  93. 6.16.2 Covis Pharmaceutical Inc Business Overview
  94. 6.16.3 Covis Pharmaceutical Inc Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Covis Pharmaceutical Inc Antiasthmatic Drug Product Portfolio
  96. 6.16.5 Covis Pharmaceutical Inc Recent Developments
  97. 6.17 Chiesi GmbH
  98. 6.17.1 Chiesi GmbH Company Information
  99. 6.17.2 Chiesi GmbH Business Overview
  100. 6.17.3 Chiesi GmbH Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Chiesi GmbH Antiasthmatic Drug Product Portfolio
  102. 6.17.5 Chiesi GmbH Recent Developments
  103. 6.18 Boehringer Ingelheim Pharma GmbH&Co.KG
  104. 6.18.1 Boehringer Ingelheim Pharma GmbH&Co.KG Company Information
  105. 6.18.2 Boehringer Ingelheim Pharma GmbH&Co.KG Business Overview
  106. 6.18.3 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Boehringer Ingelheim Pharma GmbH&Co.KG Antiasthmatic Drug Product Portfolio
  108. 6.18.5 Boehringer Ingelheim Pharma GmbH&Co.KG Recent Developments
  109. 6.19 Akorn Pharmaceutical Co.Ltd.
  110. 6.19.1 Akorn Pharmaceutical Co.Ltd. Company Information
  111. 6.19.2 Akorn Pharmaceutical Co.Ltd. Business Overview
  112. 6.19.3 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Akorn Pharmaceutical Co.Ltd. Antiasthmatic Drug Product Portfolio
  114. 6.19.5 Akorn Pharmaceutical Co.Ltd. Recent Developments
  115. 6.20 ABC Farmaceutici Spa
  116. 6.20.1 ABC Farmaceutici Spa Company Information
  117. 6.20.2 ABC Farmaceutici Spa Business Overview
  118. 6.20.3 ABC Farmaceutici Spa Antiasthmatic Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 ABC Farmaceutici Spa Antiasthmatic Drug Product Portfolio
  120. 6.20.5 ABC Farmaceutici Spa Recent Developments
7 North America
  1. 7.1 North America Antiasthmatic Drug Market Size (2021-2032)
  2. 7.2 North America Antiasthmatic Drug Market Size by Type
  3. 7.2.1 North America Antiasthmatic Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Antiasthmatic Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Antiasthmatic Drug Market Share by Type (2021-2032)
  6. 7.3 North America Antiasthmatic Drug Market Size by Application
  7. 7.3.1 North America Antiasthmatic Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Antiasthmatic Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Antiasthmatic Drug Market Share by Application (2021-2032)
  10. 7.4 North America Antiasthmatic Drug Market Size by Country
  11. 7.4.1 North America Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Antiasthmatic Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Antiasthmatic Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Antiasthmatic Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Antiasthmatic Drug Market Size (2021-2032)
  2. 8.2 Europe Antiasthmatic Drug Market Size by Type
  3. 8.2.1 Europe Antiasthmatic Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Antiasthmatic Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Antiasthmatic Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Antiasthmatic Drug Market Size by Application
  7. 8.3.1 Europe Antiasthmatic Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Antiasthmatic Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Antiasthmatic Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Antiasthmatic Drug Market Size by Country
  11. 8.4.1 Europe Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Antiasthmatic Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Antiasthmatic Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Antiasthmatic Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Antiasthmatic Drug Market Size (2021-2032)
  2. 9.2 China Antiasthmatic Drug Market Size by Type
  3. 9.2.1 China Antiasthmatic Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Antiasthmatic Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Antiasthmatic Drug Market Share by Type (2021-2032)
  6. 9.3 China Antiasthmatic Drug Market Size by Application
  7. 9.3.1 China Antiasthmatic Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Antiasthmatic Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Antiasthmatic Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Antiasthmatic Drug Market Size (2021-2032)
  2. 10.2 Asia Antiasthmatic Drug Market Size by Type
  3. 10.2.1 Asia Antiasthmatic Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Antiasthmatic Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Antiasthmatic Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Antiasthmatic Drug Market Size by Application
  7. 10.3.1 Asia Antiasthmatic Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Antiasthmatic Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Antiasthmatic Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Antiasthmatic Drug Market Size by Country
  11. 10.4.1 Asia Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Antiasthmatic Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Antiasthmatic Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Antiasthmatic Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Antiasthmatic Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Antiasthmatic Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Antiasthmatic Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Antiasthmatic Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Antiasthmatic Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Antiasthmatic Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Antiasthmatic Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Antiasthmatic Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Antiasthmatic Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Antiasthmatic Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Antiasthmatic Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Antiasthmatic Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Antiasthmatic Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Antiasthmatic Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst